152 related articles for article (PubMed ID: 33283497)
1. NANOG Decoy Oligodeoxynucleotide-Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme Cells.
Gharbavi M; Johari B; Rismani E; Mousazadeh N; Taromchi AH; Sharafi A
ACS Chem Neurosci; 2020 Dec; 11(24):4499-4515. PubMed ID: 33283497
[TBL] [Abstract][Full Text] [Related]
2. Combinational therapy with Myc decoy oligodeoxynucleotides encapsulated in nanocarrier and X-irradiation on breast cancer cells.
Johari B; Parvinzad Leilan M; Gharbavi M; Mortazavi Y; Sharafi A; Rezaeejam H
Oncol Res; 2023; 32(2):309-323. PubMed ID: 38186581
[TBL] [Abstract][Full Text] [Related]
3. Hybrid of niosomes and bio-synthesized selenium nanoparticles as a novel approach in drug delivery for cancer treatment.
Gharbavi M; Johari B; Mousazadeh N; Rahimi B; Leilan MP; Eslami SS; Sharafi A
Mol Biol Rep; 2020 Sep; 47(9):6517-6529. PubMed ID: 32767222
[TBL] [Abstract][Full Text] [Related]
4. Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cells.
Ghorbani R; Gharbavi M; Sharafi A; Rismani E; Rezaeejam H; Mortazavi Y; Johari B
Oncol Res; 2023; 32(1):101-125. PubMed ID: 38188680
[TBL] [Abstract][Full Text] [Related]
5. Targeting c-Myc with decoy oligodeoxynucleotide-loaded polycationic nanoparticles inhibits cell growth and induces apoptosis in cancer stem-like cells (NTERA-2).
Ghorbani R; Gharbavi M; Keshavarz B; Madanchi H; Johari B
Mol Biol Rep; 2024 May; 51(1):623. PubMed ID: 38710891
[TBL] [Abstract][Full Text] [Related]
6. STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells.
Ma Y; Zhang X; Xu X; Shen L; Yao Y; Yang Z; Liu P
PLoS One; 2015; 10(4):e0124924. PubMed ID: 25923701
[TBL] [Abstract][Full Text] [Related]
7. Blockage of STAT3 signaling pathway with a decoy oligodeoxynucleotide inhibits growth of human ovarian cancer cells.
Liu M; Wang F; Wen Z; Shi M; Zhang H
Cancer Invest; 2014 Jan; 32(1):8-12. PubMed ID: 24328557
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
Zhang X; Zhang J; Wang L; Wei H; Tian Z
BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
[TBL] [Abstract][Full Text] [Related]
9. [Targeted blockage of STAT5 by a decoy oligodeoxynucleotide inhibits the growth and proliferation of K562 cells].
Wang XZ; Feng WL; Shi M; Zeng JM; Tu ZG; Huang ZG
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):724-7. PubMed ID: 15730714
[TBL] [Abstract][Full Text] [Related]
10. HIF-1α decoy oligodeoxynucleotides inhibit HIF-1α signaling and breast cancer proliferation.
Zhu X; Li Q; Li S; Chen B; Zou H
Int J Oncol; 2015 Jan; 46(1):215-22. PubMed ID: 25334080
[TBL] [Abstract][Full Text] [Related]
11. Stent-based delivery of decoy oligodeoxynucleotides against activator protein-1 binding site decreased restenosis in rabbits.
Lin K; Zhao Z; Chen L
Pharmazie; 2013 Aug; 68(8):661-7. PubMed ID: 24020120
[TBL] [Abstract][Full Text] [Related]
12. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
[TBL] [Abstract][Full Text] [Related]
13. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B
Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of decoy oligodeoxynucleotides targeted to NF-kappaB in vitro and in vivo.
Wang T; Li QH; Hao GP; Zhai J
Asian Pac J Cancer Prev; 2010; 11(1):193-200. PubMed ID: 20593956
[TBL] [Abstract][Full Text] [Related]
15. Effects of NFkappaB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line.
Gill JS; Zhu X; Moore MJ; Lu L; Yaszemski MJ; Windebank AJ
Biomaterials; 2002 Jul; 23(13):2773-81. PubMed ID: 12059028
[TBL] [Abstract][Full Text] [Related]
16. Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells.
Johari B; Ebrahimi-Rad M; Maghsood F; Lotfinia M; Saltanatpouri Z; Teimoori-Toolabi L; Sharifzadeh Z; Karimipoor M; Kadivar M
Anticancer Agents Med Chem; 2017; 17(13):1786-1795. PubMed ID: 28403778
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
[TBL] [Abstract][Full Text] [Related]
18. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
[TBL] [Abstract][Full Text] [Related]
19. Development of gene therapy with a cyclic adenosine monophosphate response element decoy oligodeoxynucleotide to prevent vascular intimal hyperplasia.
Uchida D; Saito Y; Kikuchi S; Yoshida Y; Hirata S; Sasajima T; Azuma N
J Vasc Surg; 2020 Jan; 71(1):229-241. PubMed ID: 31204215
[TBL] [Abstract][Full Text] [Related]
20. Efficient Liposomal Nanocarrier-mediated Oligodeoxynucleotide Delivery Involving Dual Use of a Cell-Penetrating Peptide as a Packaging and Intracellular Delivery Agent.
Saw PE; Ko YT; Jon S
Macromol Rapid Commun; 2010 Jul; 31(13):1155-62. PubMed ID: 21590869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
